SCHEMBL12307675

SCHEMBL12307675

NC(=O)CCC(=O)Nc1cc2n(n1)CCN2c1cccc(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.40
▸ HTR7 P34969 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ HTR2A P28223 2/20 0.38
▸ HTR6 P50406 2/20 0.38
▸ CACNA1G O43497 3/20 0.38
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ NR3C2 P08235 1/20 0.36
▸ KCNQ2 O43526 1/20 0.36
▸ CACNA1H O95180 1/20 0.36
▸ CACNA1C Q13936 1/20 0.36
▸ CACNA1I Q9P0X4 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12334182 0.89 PARP1 (0.38) ALDH1A1MAPTNR3C2DRD2HPGD
SCHEMBL12307659 0.86 ALDH1A1 (0.37) ALDH1A1CACNA1GPRMT5WDR77MAPT
SCHEMBL12307660 0.85 CACNA1G (0.40) ALDH1A1POLBCACNA1GMAPTKCNQ2
SCHEMBL12307669 0.84 POLB (0.39) ALDH1A1POLBCACNA1GMAPTTHRB
SCHEMBL12307663 0.83 KCNQ2 (0.54) ALDH1A1CACNA1GKCNQ2CACNA1HCACNA1C
SCHEMBL12307618 0.82 KMT2A (0.45) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL12307647 0.80 USP2 (0.48) ALDH1A1POLBMEN1KMT2AEGFR
SCHEMBL12307489 0.80 KMT2A (0.39) HTR1AHTR7ALDH1A1HTR2AHTR6
SCHEMBL12307639 0.79 KMT2A (0.44) ALDH1A1MAPTMEN1KMT2A
SCHEMBL12307644 0.79 KDM4E (0.48) ALDH1A1POLBMAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 HTR1A 4884/4885HTR7 4650/4885ALDH1A1 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback